Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Critical Illness | 3 | 2020 | 328 | 0.590 |
Why?
|
| Capnography | 2 | 2015 | 7 | 0.490 |
Why?
|
| Intensive Care Units | 5 | 2022 | 419 | 0.460 |
Why?
|
| Syringes | 1 | 2015 | 12 | 0.460 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2015 | 20 | 0.460 |
Why?
|
| Colorimetry | 1 | 2015 | 26 | 0.450 |
Why?
|
| Respiratory System | 1 | 2015 | 47 | 0.450 |
Why?
|
| Carbon Dioxide | 1 | 2015 | 81 | 0.440 |
Why?
|
| Radiography, Thoracic | 1 | 2015 | 117 | 0.430 |
Why?
|
| Pneumonia, Ventilator-Associated | 4 | 2011 | 37 | 0.330 |
Why?
|
| Respiration, Artificial | 2 | 2002 | 294 | 0.260 |
Why?
|
| Cough | 3 | 1998 | 184 | 0.250 |
Why?
|
| Triage | 1 | 2005 | 126 | 0.210 |
Why?
|
| Patient Admission | 1 | 2005 | 197 | 0.200 |
Why?
|
| Ventilator Weaning | 1 | 2002 | 20 | 0.180 |
Why?
|
| Pneumonia | 1 | 2005 | 291 | 0.180 |
Why?
|
| Sensitivity and Specificity | 4 | 2015 | 1159 | 0.180 |
Why?
|
| Resuscitation Orders | 1 | 2022 | 49 | 0.180 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2022 | 98 | 0.170 |
Why?
|
| Quality of Health Care | 2 | 2020 | 524 | 0.170 |
Why?
|
| Early Ambulation | 1 | 2020 | 10 | 0.160 |
Why?
|
| Prospective Studies | 7 | 2015 | 3299 | 0.160 |
Why?
|
| Blood Pressure Determination | 1 | 2020 | 39 | 0.160 |
Why?
|
| Arterial Pressure | 1 | 2020 | 27 | 0.160 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 1555 | 0.160 |
Why?
|
| Calcitonin | 2 | 2010 | 17 | 0.160 |
Why?
|
| Middle Aged | 14 | 2020 | 18106 | 0.150 |
Why?
|
| Nursing Staff, Hospital | 1 | 2020 | 72 | 0.150 |
Why?
|
| Alprostadil | 1 | 1999 | 6 | 0.150 |
Why?
|
| Breath Tests | 1 | 1999 | 14 | 0.150 |
Why?
|
| Protein Precursors | 2 | 2010 | 85 | 0.150 |
Why?
|
| Hydrogen Peroxide | 1 | 1999 | 82 | 0.150 |
Why?
|
| Thrombophlebitis | 1 | 1997 | 14 | 0.140 |
Why?
|
| Femoral Vein | 1 | 1997 | 19 | 0.140 |
Why?
|
| Calorimetry, Indirect | 1 | 1997 | 32 | 0.130 |
Why?
|
| Catheterization, Central Venous | 1 | 1997 | 84 | 0.130 |
Why?
|
| Critical Care | 1 | 2020 | 402 | 0.120 |
Why?
|
| Male | 14 | 2020 | 30790 | 0.120 |
Why?
|
| Sputum | 1 | 1995 | 45 | 0.120 |
Why?
|
| Asthma | 2 | 1997 | 472 | 0.110 |
Why?
|
| Exhalation | 1 | 2015 | 15 | 0.110 |
Why?
|
| Female | 14 | 2020 | 33739 | 0.110 |
Why?
|
| Models, Animal | 1 | 2015 | 241 | 0.110 |
Why?
|
| Energy Metabolism | 1 | 1997 | 394 | 0.100 |
Why?
|
| Swine | 1 | 2015 | 394 | 0.100 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 315 | 0.100 |
Why?
|
| Humans | 18 | 2022 | 64729 | 0.100 |
Why?
|
| Glycopeptides | 1 | 2011 | 12 | 0.090 |
Why?
|
| Aged | 10 | 2011 | 14834 | 0.090 |
Why?
|
| Lithostathine | 1 | 2011 | 1 | 0.090 |
Why?
|
| Organ Dysfunction Scores | 1 | 2011 | 23 | 0.090 |
Why?
|
| Adult | 10 | 2020 | 17230 | 0.090 |
Why?
|
| Aged, 80 and over | 5 | 2009 | 5562 | 0.080 |
Why?
|
| Multiple Organ Failure | 1 | 2011 | 46 | 0.080 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2010 | 6 | 0.080 |
Why?
|
| Pleural Effusion | 1 | 1990 | 39 | 0.080 |
Why?
|
| Pilot Projects | 2 | 2011 | 1001 | 0.060 |
Why?
|
| ROC Curve | 3 | 2011 | 292 | 0.060 |
Why?
|
| Respiratory Function Tests | 2 | 1997 | 194 | 0.060 |
Why?
|
| Community-Acquired Infections | 1 | 2005 | 93 | 0.050 |
Why?
|
| Chronic Disease | 2 | 1998 | 745 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 1633 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 1997 | 989 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 801 | 0.050 |
Why?
|
| Cost Control | 1 | 2002 | 24 | 0.050 |
Why?
|
| APACHE | 1 | 2002 | 42 | 0.050 |
Why?
|
| Diagnosis-Related Groups | 1 | 2002 | 86 | 0.050 |
Why?
|
| Propensity Score | 1 | 2022 | 188 | 0.040 |
Why?
|
| Biomarkers | 3 | 2011 | 1465 | 0.040 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 2010 | 11 | 0.040 |
Why?
|
| United States | 2 | 2020 | 8041 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 1999 | 100 | 0.040 |
Why?
|
| Trauma Centers | 1 | 2020 | 131 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2022 | 6803 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 1999 | 175 | 0.040 |
Why?
|
| Liposomes | 1 | 1999 | 116 | 0.040 |
Why?
|
| Length of Stay | 1 | 2002 | 822 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2005 | 2086 | 0.030 |
Why?
|
| Metaproterenol | 1 | 1997 | 2 | 0.030 |
Why?
|
| Bronchoconstrictor Agents | 1 | 1997 | 5 | 0.030 |
Why?
|
| Bronchial Provocation Tests | 1 | 1997 | 17 | 0.030 |
Why?
|
| Methacholine Chloride | 1 | 1997 | 23 | 0.030 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1997 | 34 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2002 | 872 | 0.030 |
Why?
|
| Drug Carriers | 1 | 1999 | 187 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2010 | 5758 | 0.030 |
Why?
|
| Animals | 1 | 2015 | 21292 | 0.030 |
Why?
|
| Prognosis | 2 | 2011 | 1770 | 0.030 |
Why?
|
| Bronchodilator Agents | 1 | 1997 | 121 | 0.030 |
Why?
|
| Geriatrics | 1 | 1997 | 50 | 0.030 |
Why?
|
| Anti-Asthmatic Agents | 1 | 1997 | 41 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 1997 | 213 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 1997 | 162 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 727 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 1997 | 134 | 0.030 |
Why?
|
| Remission Induction | 1 | 1995 | 149 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 622 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 1995 | 371 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 1995 | 414 | 0.030 |
Why?
|
| Patient Compliance | 1 | 1997 | 365 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 1997 | 1689 | 0.020 |
Why?
|
| Adolescent | 2 | 2009 | 6291 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 414 | 0.020 |
Why?
|
| Risk | 1 | 2010 | 376 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 497 | 0.020 |
Why?
|
| Survival Rate | 1 | 2011 | 847 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2009 | 158 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2009 | 734 | 0.020 |
Why?
|
| Time Factors | 2 | 2009 | 3745 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 1997 | 164 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 1997 | 159 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1997 | 740 | 0.010 |
Why?
|